Beam’s medicine uses a technology known as base editing to activate a gene in stem cells collected from people with sickle ...
Almost a year after two historic approvals, Pfizer is pulling a sickle cell disease treatment from the market, and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback